mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-07 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |